Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors.
Rajiv C PatelDivision of Cardiology and McAllister Heart Institute, School of Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA.ORCID 0009-0007-0206-7689
Cameron D ThomasDepartment of Pharmacotherapy & Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy University of Florida Gainesville FL USA.ORCID 0000-0001-5040-2313
Joseph S RossiDivision of Cardiology and McAllister Heart Institute, School of Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA.
Francesco FranchiDivision of Cardiology, Department of Medicine, College of Medicine-Jacksonville University of Florida Jacksonville FL USA.ORCID 0000-0001-8503-5736
Ellen C KeeleyDivision of Cardiovascular Medicine, College of Medicine University of Florida Gainesville FL USA.ORCID 0000-0003-2915-4751
Amber L BeitelsheesDepartment of Medicine and Program for Personalized and Genomic Medicine University of Maryland School of Medicine Baltimore MD USA.ORCID 0000-0003-0958-7197
Julio D DuarteDepartment of Pharmacotherapy & Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy University of Florida Gainesville FL USA.ORCID 0000-0001-9766-4038
Luis Ortega-PazDivision of Cardiology, Department of Medicine, College of Medicine-Jacksonville University of Florida Jacksonville FL USA.
Natasha KulickDivision of Cardiology and McAllister Heart Institute, School of Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA.ORCID 0009-0002-2194-6383
Marshall WingetDivision of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC USA.ORCID 0009-0004-2158-5260
Anh B NguyenDivision of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC USA.ORCID 0000-0002-4177-7874
William E YangDepartment of Medicine and Program for Personalized and Genomic Medicine University of Maryland School of Medicine Baltimore MD USA.ORCID 0000-0002-9912-8543
Sanjay VenkateshDivision of Cardiology and McAllister Heart Institute, School of Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA.
Dominick J AngiolilloDivision of Cardiology, Department of Medicine, College of Medicine-Jacksonville University of Florida Jacksonville FL USA.ORCID 0000-0001-8451-2131
Larisa H CavallariDepartment of Pharmacotherapy & Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy University of Florida Gainesville FL USA.ORCID 0000-0002-7184-5292
Craig R LeeDivision of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC USA.ORCID 0000-0003-3595-5301
George A StoufferDivision of Cardiology and McAllister Heart Institute, School of Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA.ORCID 0000-0001-8208-8998
Funding
North Carolina Translational and Clinical Sciences Institute (NC TraCS)UM1TR004406 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NICHOLAS J SHAHEEN · 2023 to 2026
$37.5M
Using social networks to map and evaluate team science across CTSA hubsUL1TR001427 · NCATS · UNIVERSITY OF FLORIDA · PI MITCHELL, DUANE A. · 2015 to 2024
$37.2M
Sparking Advancements in Genomic MedicineU01HG007269 · NHGRI · UNIVERSITY OF FLORIDA · PI CAVALLARI, LARISA HUMMA, JOHNSON, JULIE A. · 2013 to 2024
$17.0M
Precision antiplatelet therapy after percutaneous coronary interventionR01HL149752 · NHLBI · UNIVERSITY OF FLORIDA · PI CAVALLARI, LARISA HUMMA, LEE, CRAIG R · 2020 to 2024
methodsThis was a retrospective, multicenter cohort study. Patients were characterized as intermediate or poor metabolizers versus normal or rapid or ultrarapid metabolizers on the basis of
resultsThe study population (N=4246) had a median age of 63.0 (interquartile range, 55.0-71.0) years, was 66.8% men, and 21.3% Black individuals. During 12-month follow-up, major adverse cardiovascular event rates were higher (7.4% versus 4.8%;
conclusionsPatients on maintenance clopidogrel at the time of percutaneous coronary intervention represent a higher-risk patient population than patients who are naïve to P2Y
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.